drugset / Trial / NCT01097317

First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer

NCT01097317

Phase 2 Unknown 52 enrolled Wales Cancer Trials Unit
RandomizedOpen-labelSupportive care

Summary

RATIONALE: Drugs used in chemotherapy, such as carboplatin and vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Chemotherapy can lead to a loss of leg muscle strength. Neuromuscular electrical stimulation may improve muscle strength and quality of life. It is not yet known whether chemotherapy given together with neuromuscular electrical stimulation is more effective than chemotherapy alone in treating patients with non-small cell lung cancer. PURPOSE: This randomized phase II trial is studying first-line chemotherapy given together with neuromuscular electrical stimulation to see how well it works compared with chemotherapy alone in treating patients with non-small cell lung cancer.

Timeline

Start
2009-09
Primary completion
2011-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Carboplatin Small molecule
Background Vinorelbine Small molecule